Artivion (AORT) News Today $24.72 -0.25 (-1.00%) As of 01:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Do Options Traders Know Something About Artivion (AORT) Stock We Don't?March 24 at 11:36 PM | finance.yahoo.comArtivion, Inc. (NYSE:AORT) Shares Bought by AmundiAmundi raised its position in Artivion, Inc. (NYSE:AORT - Free Report) by 174.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 18,288 shares of the company's stock after buying an additional 11,634 shares during the quarter. Amundi's holdings in Artivion wMarch 21, 2025 | marketbeat.comRoyce & Associates LP Sells 40,170 Shares of Artivion, Inc. (NYSE:AORT)Royce & Associates LP lessened its stake in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 4.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 831,000 shares of the company's stock after selling 40,170 shares duriMarch 17, 2025 | marketbeat.comFirst Eagle Investment Management LLC Reduces Stock Holdings in Artivion, Inc. (NYSE:AORT)First Eagle Investment Management LLC reduced its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 4.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 591,715 shares of the company's stock after selling 30,133 shaMarch 15, 2025 | marketbeat.comArtivion, Inc. (NYSE:AORT) Insider John E. Davis Sells 15,100 SharesArtivion, Inc. (NYSE:AORT - Get Free Report) insider John E. Davis sold 15,100 shares of Artivion stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $23.61, for a total value of $356,511.00. Following the completion of the sale, the insider now owns 208,778 shares in the company, valued at approximately $4,929,248.58. This trade represents a 6.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.March 13, 2025 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) SVP Sells 18,020 Shares of StockArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean F. Holloway sold 18,020 shares of Artivion stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $23.61, for a total value of $425,452.20. Following the completion of the transaction, the senior vice president now owns 197,184 shares in the company, valued at $4,655,514.24. The trade was a 8.37 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.March 13, 2025 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) Insider Sells 15,100 Shares of StockMarch 13, 2025 | insidertrades.comArtivion, Inc. (NYSE:AORT) SVP Jean F. Holloway Sells 472 SharesArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean F. Holloway sold 472 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $25.29, for a total transaction of $11,936.88. Following the completion of the transaction, the senior vice president now directly owns 172,743 shares of the company's stock, valued at approximately $4,368,670.47. This trade represents a 0.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.March 7, 2025 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) SVP Sells 472 Shares of StockMarch 7, 2025 | insidertrades.comArtivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 4, 2025 | prnewswire.comLance A. Berry Sells 3,259 Shares of Artivion, Inc. (NYSE:AORT) StockArtivion, Inc. (NYSE:AORT - Get Free Report) CFO Lance A. Berry sold 3,259 shares of Artivion stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $27.31, for a total transaction of $89,003.29. Following the completion of the transaction, the chief financial officer now directly owns 75,805 shares in the company, valued at $2,070,234.55. This represents a 4.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.February 27, 2025 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) SVP Sells 5,335 Shares of StockArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean F. Holloway sold 5,335 shares of Artivion stock in a transaction on Monday, February 24th. The shares were sold at an average price of $27.31, for a total value of $145,698.85. Following the completion of the transaction, the senior vice president now owns 149,799 shares in the company, valued at approximately $4,091,010.69. The trade was a 3.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.February 27, 2025 | marketbeat.comArtivion, Inc. (NYSE:AORT) Insider John E. Davis Sells 6,457 SharesArtivion, Inc. (NYSE:AORT - Get Free Report) insider John E. Davis sold 6,457 shares of the company's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $27.31, for a total value of $176,340.67. Following the sale, the insider now owns 160,631 shares of the company's stock, valued at $4,386,832.61. This trade represents a 3.86 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.February 27, 2025 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) CEO Sells 42,156 Shares of StockArtivion, Inc. (NYSE:AORT - Get Free Report) CEO James P. Mackin sold 42,156 shares of the company's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $27.31, for a total value of $1,151,280.36. Following the completion of the sale, the chief executive officer now owns 663,882 shares in the company, valued at $18,130,617.42. This represents a 5.97 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.February 27, 2025 | marketbeat.comArtivion, Inc. (NYSE:AORT) CFO Sells $89,003.29 in StockFebruary 27, 2025 | insidertrades.comArtivion price target lowered to $32 from $34 at NeedhamFebruary 26, 2025 | markets.businessinsider.comArtivion price target lowered to $30 from $33 at StifelFebruary 26, 2025 | markets.businessinsider.comArtivion (AORT) Stock Trades Down, Here Is WhyFebruary 26, 2025 | msn.comArtivion (NYSE:AORT) Releases Earnings Results, Misses Expectations By $0.51 EPSArtivion (NYSE:AORT - Get Free Report) announced its earnings results on Monday. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.51). The business had revenue of $97.31 million for the quarter, compared to analyst estimates of $100.82 million. Artivion had a negative net margin of 0.22% and a positive return on equity of 5.15%.February 25, 2025 | marketbeat.comArtivion (NYSE:AORT) Shares Gap Down Following Analyst DowngradeArtivion (NYSE:AORT) Shares Gap Down Following Analyst DowngradeFebruary 25, 2025 | marketbeat.comArtivion (NYSE:AORT) Price Target Lowered to $30.00 at Stifel NicolausStifel Nicolaus cut their target price on Artivion from $33.00 to $30.00 and set a "buy" rating for the company in a research note on Tuesday.February 25, 2025 | marketbeat.comNeedham & Company LLC Cuts Artivion (NYSE:AORT) Price Target to $32.00Needham & Company LLC lowered their price target on Artivion from $34.00 to $32.00 and set a "buy" rating for the company in a report on Tuesday.February 25, 2025 | marketbeat.comArtivion, Inc.: Artivion Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | finanznachrichten.deArtivion, Inc. (AORT) Q4 2024 Earnings Call TranscriptFebruary 24, 2025 | seekingalpha.comArtivion, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 24, 2025 | seekingalpha.comArtivion shares tumble on revenue miss and weak guidanceFebruary 24, 2025 | in.investing.comLake Street Remains a Buy on Artivion (AORT)February 24, 2025 | markets.businessinsider.comArtivion reports Q4 non-GAAP EPS 0c, consensus 4cFebruary 24, 2025 | markets.businessinsider.comArtivion (NYSE:AORT) Misses Q4 Sales TargetsFebruary 24, 2025 | msn.comArtivion Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 24, 2025 | prnewswire.comArtivion (AORT) Q4 Earnings: What To ExpectFebruary 23, 2025 | msn.comArtivion (AORT) Projected to Post Quarterly Earnings on ThursdayArtivion (NYSE:AORT) will be releasing earnings before the market opens on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=432809)February 13, 2025 | marketbeat.comArtivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial ResultsFebruary 10, 2025 | prnewswire.comSG Americas Securities LLC Sells 9,689 Shares of Artivion, Inc. (NYSE:AORT)SG Americas Securities LLC lowered its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 57.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,197 shares of the company's stock after selling 9,689 shares during the period. SG Americas SecuriFebruary 8, 2025 | marketbeat.comArtivion, Inc. (NYSE:AORT) Shares Purchased by Calamos Advisors LLCCalamos Advisors LLC raised its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 113.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 63,029 shares of the company's stock after buying an additional 33,541 shares during the quarter.February 5, 2025 | marketbeat.comArtivion, Inc. (AORT) Stock ForecastsJanuary 31, 2025 | ca.finance.yahoo.comPositive Trial Data and FDA Prospects Drive Buy Rating for ArtivionJanuary 28, 2025 | markets.businessinsider.comArtivion Receives Buy Rating from Michael Matson Following Promising Clinical Trial Results and Market Expansion OpportunitiesJanuary 28, 2025 | markets.businessinsider.comArtivion's (AORT) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $34.00 price objective on shares of Artivion in a research note on Tuesday.January 28, 2025 | marketbeat.comOppenheimer maintains Artivion stock with $32 targetJanuary 28, 2025 | msn.comArtivion presents data on AMDS in DeBakey aortic dissectionsJanuary 28, 2025 | markets.businessinsider.comOppenheimer maintains Artivion Outperform with $32 targetJanuary 28, 2025 | msn.comArtivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual MeetingJanuary 27, 2025 | prnewswire.comJPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT)JPMorgan Chase & Co. raised its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 394.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,903 shares of the company's stock after buying aJanuary 21, 2025 | marketbeat.comIs Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | insidermonkey.comArtivion (NYSE:AORT) Reaches New 1-Year High - Here's WhyArtivion (NYSE:AORT) Reaches New 12-Month High - Here's What HappenedJanuary 16, 2025 | marketbeat.comArtivion (AORT) Gets a Buy from Lake StreetJanuary 7, 2025 | markets.businessinsider.comBarclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT)Barclays PLC raised its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 346.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 70,877 shares of the company's stock after acquiring an additional 54,996 shares during the quarter. Barclays PLDecember 27, 2024 | marketbeat.comJane Street Group LLC Purchases 24,945 Shares of Artivion, Inc. (NYSE:AORT)Jane Street Group LLC increased its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 69.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,035 shares of the company's stock after acquiring an adDecember 27, 2024 | marketbeat.comArtivion: Current Valuation Seems StretchedDecember 26, 2024 | seekingalpha.com Remove Ads Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address AORT Media Mentions By Week AORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AORT News Sentiment▼0.840.63▲Average Medical News Sentiment AORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AORT Articles This Week▼23▲AORT Articles Average Week Remove Ads Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies iRhythm Technologies News Today PROCEPT BioRobotics News Today Envista News Today TransMedics Group News Today Soleno Therapeutics News Today LivaNova News Today Enovis News Today NovoCure News Today Warby Parker News Today LeMaitre Vascular News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AORT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
